Better Therapeutics, Inc.
BTTX
$0.0002
$0.000.00%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -5.86M | -7.59M | -9.36M | -8.77M | -11.41M |
| Total Depreciation and Amortization | 841.00K | 797.00K | 755.00K | -1.96M | 694.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | 2.68M | -- |
| Total Other Non-Cash Items | 427.00K | 478.00K | 410.00K | 449.00K | 608.00K |
| Change in Net Operating Assets | -1.35M | 1.23M | -524.00K | 1.26M | 3.09M |
| Cash from Operations | -5.94M | -5.09M | -8.72M | -6.34M | -7.01M |
| Capital Expenditure | -5.00K | 0.00 | -26.00K | -14.00K | -23.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 71.00K | -503.00K | -495.00K | -346.00K | -351.00K |
| Cash from Investing | 66.00K | -503.00K | -521.00K | -360.00K | -374.00K |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | 0.00 | -423.00K | -435.00K | -- | -- |
| Issuance of Common Stock | 6.72M | 6.54M | -- | 132.00K | 6.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -444.00K | -400.00K | -- | -- | -- |
| Cash from Financing | 6.28M | 5.72M | -435.00K | 132.00K | 6.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 402.00K | 128.00K | -9.67M | -6.57M | -7.38M |
